Abstract
Osteoporosis is a major cause of morbidity and mortality through its association with age-related fractures. Although most effort in fracture prevention has been directed at retarding the rate of age-related bone loss and reducing the frequency and severity of trauma among elderly people, evidence is growing that peak bone mass is an important contributor to bone strength during later life. The normal patterns of skeletal growth have been well characterised in cross-sectional and longitudinal studies. It has been confirmed that boys have higher bone mineral content (BMC), but not volumetric bone density, than girls. Furthermore, there is a dissociation between the peak velocities for height gain and bone mineral accrual in both genders. Puberty is the period during which volumetric density appears to increase in both axial and appendicular sites. Many factors influence the accumulation of bone mineral during childhood and adolescence, including heredity, gender, diet, physical activity, endocrine status, and sporadic risk factors such as cigarette smoking. In addition to these modifiable factors during childhood, evidence has also accrued that fracture risk might be programmed during intrauterine life. Epidemiological studies have demonstrated a relationship between birth weight, weight in infancy, and adult bone mass. This appears to be mediated through modulation of the setpoint for basal activity of pituitary-dependent endocrine systems such as the HPA and GH/IGF-1 axes. Maternal smoking, diet (particularly vitamin D deficiency), and physical activity also appear to modulate bone mineral acquisition during intrauterine life; furthermore, both low birth size and poor childhood growth are directly linked to the later risk of hip fracture. The optimisation of maternal nutrition and intrauterine growth should also be included within preventive strategies against osteoporotic fracture, albeit for future generations.
Similar content being viewed by others
References
Consensus Development Conference (1991) Prophylaxis and treatment of osteoporosis. Osteoporosis Int 1:114–117
Cooper C (2003) Epidemiology of osteoporosis. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 5th edn. American Society for Bone and Mineral Research, pp 307–313
Ralston SH (1998) Do genetic markers aid in risk assessment? Osteoporosis Int 8:S37–S42
Bateson P (2001) Fetal experience and good adult disease. Int J Epidemiol 30:928–934
Matkovic V, Jelic T, Wardlaw GM, Ilich JZ, Goel PK, Wright JK, et al. (1994) Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. J Clin Invest 93:799–808
Seeman E (2002) Pathogenesis of bone fragility in women and men. Lancet 359:1841–1850
Seeman E (2004) The growth and age related origins of bone fragility in men. Calcif Tissue Int 75:100–109
Bailey DA, McKay HA, Mirwald RL, Crocker PR, Faulkner RA (1999) A six year longitudinal study of the relationship with physical activity to bone mineral accrual in growing children: the University of Saskatchewan bone mineral accrual study. J Bone Min Res 14:1672–1679
Newton John HF, Morgan BD (1970) The loss of bone with age: osteoporosis and fractures. Clin Orthop 71:229–232
Ferrari S, Rizzoli R, Slosman D, Bonjour JP (1998) Familial resemblance for bone mineral mass is expressed before puberty. J Clin Endocrinol Metab 83:358–361
DeLise AM, Fischer L, Tuan RS (2000) Cellular interactions and signalling in cartilage development. Osteoarthritis Cartilage 8:309–334
Karaplis AC, Luz A, Glowacki J, et al. (1994) Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8:277–289
Bhaumick B, Bala RM (1991) Differential effects of insulin-like growth factors I and II on growth, differentiation and glucoregulation in differentiating chondrocyte cells in culture. Acta Endocrinol (Copenh) 125:201–211
Sylvia VL, Del Toro F, Hardin RR, Dean DD, Boyan BD, Schwartz Z (2001) Characterization of PGE(2) receptors (EP) and their role as mediators of 1alpha,25-(OH)(2)D(3) effects on growth zone chondrocytes. J Steroid Biochem Mol Biol 78:261–274
Quarto R, Campanile G, Cancedda R, Dozin B (1997) Modulation of commitment, proliferation, and differentiation of chondrogenic cells in defined culture medium. Endocrinology 138:4966–4976
Ducy P (2000) Cbfa1: a molecular switch in osteoblast biology. Dev Dyn 219:461–471
Schauberger CW, Pitkin RM (1979) Maternal-perinatal calcium relationships. Obstet Gynecol 53:74–76
Forester F, Daffos F, Rainaut M, Bruneau M, Trivin F (1987) Blood chemistry of normal human fetuses at mid-trimester of pregnancy. Paed Res 21:579
Kovacs CS (2003) Skeletal physiology: fetus and neonate. In: Favus MJ (ed). Primer on the metabolic bone diseases and disorders of mineral metabolism, 5th edn. ASBMR, Washington DC, pp 65–71
Calvi LM et al. (2001) Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest 107:277–286
Lanske B et al. (1999) Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J Clin Invest 104:399–407
Namgung R, Tsang RC, Li C, Han DG, Ho ML, Sierra RI (1998) Low total body bone mineral content and high bone resorption in Korean winter-born versus summer-born newborn infants. J Paed 132:285–288
Specker BL, Namgung R, Tsang RC (2001) Bone mineral acquisition in utero, during infancy, and throughout childhood. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis, 2nd edn. Academic Press, New York, pp 599–620
Barker DJP (1995) The fetal origins of adult disease. Proc Royal Soc of Lond 262:37–43
Barker DJP (1995) Fetal origins of coronary heart disease. BMJ 311:171–174
Lucas A (1991) Programming by early nutrition in man. In: Bock GR, Whelan J (eds) The childhood environment and adult disease. John Wiley, New York, pp 38–55
Widdowson EM, McCance RA (1974) The determinants of growth and form. Proc Royal Soc Lond 185:1–17
Cooper C, Cawley MID, Bhalla A, Egger P, Ring F, Morton L, Barker D (1995) Childhood growth, physical activity and peak bone mass in women. J Bone Min Res 10:940–947
Cooper C, Fall C, Egger P, Hobbs R, Eastell R, Barker D (1997) Growth in infancy and bone mass in later life. Ann Rheum Dis 56:17–21
Dennison EM, Syddall HE, Sayer AA, Gilbody HJ, Cooper C (2005) Birth weight and weight at 1 year are independent determinants of bone mass in the seventh decade: the Hertfordshire cohort study. Pediatr Res 57(4):582–586
Keen R, Egger P, Fall C, Major P, Lanchbury J, Spector TD, Cooper C (1997) Polymorphisms of the vitamin D receptor, infant growth and adult bone mass. Calcif Tiss Int 60:233–235
Dennison EM, Arden NK, Keen RW, Syddall H, Day INM, Spector TD, Cooper C (2001) Birthweight, vitamin D receptor genotype and the programming of osteoporosis. Paed Peri Epidemiol 15:211–219
Antoniades L, MacGregor AJ, Andrew T, Spector TD (2003) Association of birthweight with osteoporosis and osteoarthritis in adult twins. Rheumatology 42:791–796
Fall C, Hindmarsh P, Dennison E, Kellingray S, Barker D, Cooper C (1998) Programming of growth hormone secretion and bone mineral density in elderly men; an hypothesis. J Clin Endocrinol Metab 83:135–139
Dennison E, Hindmarsh P, Fall C, Kellingray S, Barker D, Phillips D, Cooper C (1999) Profiles of endogenous circulating cortisol and bone mineral density in healthy elderly men. J Clin Endocrinol Metab 84:3058–3063
Phillips DIW, Barker DJP, Fall CHD, et al. (1998) Elevated plasma cortisol concentrations: a link between low birthweight and the insulin resistance syndrome? J Clin Endocrinol Metab 83:757–760
Dennison EM, Syddall HE, Rodriguez S, Voropanov A, Day INM, Cooper C, and the Southampton Genetic Epidemiology Research Group (2004) Polymorphism in the growth hormone gene, weight in infancy, and adult bone mass. J Clin Endocrinol Metab 89:4898–4903
Godfrey K, Walker-Bone K, Robinson S, Taylor P, Shore S, Wheeler T, Cooper C (2001) Neonatal bone mass: influence of parental birthweight, maternal smoking, body composition, and activity during pregnancy. J Bone Min Res 16:1694–1703
Harvey NCW, Javaid MK, Taylor P, Crozier SR, Gale CR, Dennison EM, Godfrey KM, Cooper C (2004) Umbilical cord calcium and maternal vitamin D status predict different lumbar spine bone parameters in the offspring at 9 years. J Bone Min Res 19:1032 [abstract]
Zamora SA, Rizzoli R, Belli DC, Slosman DO, Bonjour JP (1999) Vitamin D supplementation during infancy is associated with higher bone mineral mass in prepubertal girls. J Clin Endocrinol Metab 84:4541–4544
Cooper C, Eriksson JG, Forsén T, Osmond C, Tuomilehto J, Barker DJP (2001) Maternal height, childhood growth and risk of hip fracture in later life: a longitudinal study. Osteoporosis Int 12:623–629
Bertram CE, Hanson MA (2001) Animal models and programming of the metabolic syndrome. Br Med Bull 60:103–121
Gluckman PD, Hanson MA (2004) Living with the past: evolution, development and patterns of disease. Science 305:1733–1736
Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD (2000) Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab 279:E83–E87
Kind KL, Roberts CT, Sohlstrom AI et al. (2005) Chronic maternal feed restriction impairs growth but increases adiposity of the fetal guinea pig. Am J Physiol Regul Integra Physiol 288:R119–R126
Langley-Evans S, Gardner DS, Jackson AA (1996) Maternal protein restriction influences the programming of the rat hypothalamic-pituitary-adrenal axis. J Nutrition 126:1578–1585
Plagemann A, Harder T, Rake A, Voits M, Fink H, Rohde W, Dorner G (1999) Perinatal elevation of hypothalamic insulin, acquired malformation of hypothalamic galaninergic neurons, and syndrome x-like alterations in adulthood of neonatally overfed rats. Brain Res 836:146–155
Khan IY, Taylor PD, Dekou V, Seed PT, Lakasing L, Graham D, Dominiczak AF, Hanson MA, Poston L (2003) Gender-linked hypertension in offspring of lard-fed pregnant rats. Hypertension 41:168–75
Mehta G, Roach HI, Langley-Evans S, Taylor P, Reading I, Oreffo ROC, Aihie Sayer A, Clarke NMP, Cooper C (2002) Intrauterine exposure to a maternal low protein diet reduces adult bone mass and alters growth plate morphology in rats. Calcif Tiss Int 71:493–498
Oreffo ROC, Lashbrooke B, Roach HI, Clarke NMP, Cooper C (2003) Maternal protein deficiency affects mesenchymal stem cell activity in the developing offspring. Bone 33:100–107
West-Eberhard MJ (2003) Developmental plasticity and evolution, 1st edn. Oxford University Press, New York
Cooney CA, Dave AA, Wolff GL (2002) Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr 132(Suppl. 8):2393S–2400S
Weaver IC, Cervoni N, Champagne FA, D’Alessio AC, Sharma S, Seckl JR, Dymov S, Szyf M, Meaney MJ (2004) Epigenetic programming by maternal behavior. Nat Neurosci 7:847–854
Kwong WY, Wild AE,Roberts P, Willis AC, Fleming TP (2000) Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development 127(19):4195–4202
Javaid MK, Godfrey KM, Taylor P, et al. (2004) Umbilical venous IGF-1 concentration, neonatal bone mass, and body composition. J Bone Min Res 19:56–63
Acknowledgements
We are grateful to the Medical Research Council, the Wellcome Trust, the Arthritis Research Campaign, the National Osteoporosis Society, and the Cohen Trust for support of our research programme into the developmental origins of osteoporotic fracture. K.J. received an ARC Clinical Research Fellowship. The manuscript was prepared by Mrs. G. Strange.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cooper, C., Westlake, S., Harvey, N. et al. Review: developmental origins of osteoporotic fracture. Osteoporos Int 17, 337–347 (2006). https://doi.org/10.1007/s00198-005-2039-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-005-2039-5